Correlation Study Between the Classification of Arthrogenic Motor Inhibition (AMI) and Clinical Assessment After ACL Rupture

NANot yet recruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
ACL - Anterior Cruciate Ligament Rupture
Interventions
OTHER

Clinical testing

"Intervention includes :~* Surface EMG to measure inhibition of the VM and the rectus femoris (RF) on the injured and non-injured sides during attempts at voluntary contractions of the knee extensor muscles.~* Myotonometry to measure the stiffness of the semimembranosus and biceps femoris (long head) on the injured and non-injured sides under resting conditions"

Trial Locations (1)

69008

Hôpital Privé Jean Mermoz, Lyon

All Listed Sponsors
lead

GCS Ramsay Santé pour l'Enseignement et la Recherche

OTHER

NCT06945133 - Correlation Study Between the Classification of Arthrogenic Motor Inhibition (AMI) and Clinical Assessment After ACL Rupture | Biotech Hunter | Biotech Hunter